Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients

Background: Acyclovir represents the first-line prophylaxis and therapy for herpes virus infections. However, its pharmacokinetics in children exposes them to the risk of ineffective or toxic concentrations. The study was aimed at investigating the population pharmacokinetics (POP/PK) of intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Maximova, Natalia, Nisticò, Daniela, Luci, Giacomo, Simeone, Roberto, Piscianz, Elisa, Segat, Ludovica, Barbi, Egidio, Di Paolo, Antonello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050193/
https://www.ncbi.nlm.nih.gov/pubmed/35496277
http://dx.doi.org/10.3389/fphar.2022.865871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050193/
https://www.ncbi.nlm.nih.gov/pubmed/35496277
http://dx.doi.org/10.3389/fphar.2022.865871

Ejemplares similares